Responses
Section 4: Clinical pharmacy services
4CPS-301 Association of antibiotics and proton pump inhibitors on clinical activity of firstline pembrolizumab for non-small cell lung cancer: 2 years of real world data
Compose a Response to This Article
Other responses
No responses have been published for this article.